What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Dr. Agarwals Health Care Limited IPO?

Dr. Agarwals Health Care Limited IPO has received a total subscription of 1.55 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Dr. Agarwals Health Care Limited

ListedMainboard

Healthcare sector · NSE / BSE

Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.

Price Band

₹382 – ₹402

Issue Size

₹3027 Cr

Lot Size

35 shares

GMP

₹4

-1.0%

Est. Listing

₹398

at current GMP

Subscribed

1.55x

overall

Open

29 Jan 2025

31 Jan 2025

Allotment

1 Feb 2025

Refund

2 Feb 2025

Demat Credit

3 Feb 2025

Listing

4 Feb 2025

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

1.55x

Total Demand

QIB Multiplier

4.64x

Institutions & Funds

NII / HNI

0.40x

High Net-Worth

Retail (RII)

0.41x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 1.55x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	14,519,200	67,361,280	4.64x
NIB	10,889,400	4,307,310	0.40x
HNIs(10L +)	7,259,600	2,285,955	0.31x
HNIs (2-10L)	3,629,800	2,021,355	0.56x
RETAIL	25,408,599	10,540,285	0.41x
EMPLOYEES	1,579,399	425,565	0.27x
Shareholder	1,129,574	583,940	0.52x
Total	64,415,572	87,525,690	1.55x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 0.30x

Category	Applications Reserved	Applications Received	Times Subscribed
RETAIL	725,960	216,584	0.30x
HNIs(10L +)	13,828	846	0.06x
HNIs (2-10L)	6,914	3,432	0.50x
Total Applications	746,702	220,862	0.30x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Dr. Agarwals Health Care Limited Public Issue & Market Profile

Dr. Agarwals Health Care Limited is bringing an initial public offering (IPO) in the Healthcare sector sector with an aggregate issue size of ₹3,027.26 Crores. The shares are offered at a price band of ₹382 to ₹402 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 35 shares (approx. ₹14,070 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-02-03, while un-allotted funds or UPI block mandates will be released on 2025-02-02.

Frequently Asked Questions

What is Dr. Agarwals Health Care Limited IPO GMP today?

Currently, Dr. Agarwals Health Care Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹382 to ₹402 per equity share.

What is the expected profit per lot for Dr. Agarwals Health Care Limited IPO?

The retail lot size is 35 shares requiring a minimum application amount of ₹14,070. Expected listing price is ₹398 per equity share.

What is the issue size and price band for Dr. Agarwals Health Care Limited IPO?

The Dr. Agarwals Health Care Limited IPO aggregate issue size is ₹3,027.26 Crores with an equity price band set at ₹382 to ₹402 per equity share. The retail lot size is 35 shares requiring a minimum capital outlay of approx. ₹14,070.

How can I check Dr. Agarwals Health Care Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.55x (Retail: 0.41x, QIB: 4.64x, NII: 0.40x). You can track live multiples directly on our dedicated subscription page.

Where and when will Dr. Agarwals Health Care Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-02-01. Investors can verify status using PAN card or application number.

When is the listing date for Dr. Agarwals Health Care Limited IPO?

Dr. Agarwals Health Care Limited shares are scheduled to list on NSE and BSE on 2025-02-04.